Furthermore, we could measure a higher binding of eIF4A1 to NFKBIA mRNA in CLL than in healthy-donor PBMCs, using an RNA immunoprecipitation assay (RIP) (Figure 2D). This evidence concerns the gene NFKBIA and B-cell chronic lymphocytic leukemia.